These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22566872)

  • 41. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
    Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
    Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction.
    Fecteau JF; Roy A; Néron S
    Immunology; 2009 Sep; 128(1 Suppl):e353-65. PubMed ID: 19016905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Brokstad KA; Jakobsen K; Jonsson R; Skarstein K
    Autoimmunity; 2012 Nov; 45(7):547-55. PubMed ID: 22849322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency.
    Lemarquis AL; Einarsdottir HK; Kristjansdottir RN; Jonsdottir I; Ludviksson BR
    Front Immunol; 2018; 9():909. PubMed ID: 29755476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.
    Zhan F; Tian E; Bumm K; Smith R; Barlogie B; Shaughnessy J
    Blood; 2003 Feb; 101(3):1128-40. PubMed ID: 12393520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential therapeutic targets in plasma cell disorders: A flow cytometry study.
    Lisenko K; Schönland S; Hegenbart U; Wallenwein K; Braun U; Mai EK; Hillengass J; Goldschmidt H; Jauch A; Ho AD; Raab M; Hundemer M
    Cytometry B Clin Cytom; 2017 Mar; 92(2):145-152. PubMed ID: 26666746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD19
    Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
    DNA Cell Biol; 2017 Oct; 36(10):870-877. PubMed ID: 28829194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.
    Xu M; Jiang Y; Wang J; Liu J; Liu C; Liu D; Yang S
    BMC Immunol; 2019 Jun; 20(1):16. PubMed ID: 31159728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type I interferon promotes the fate of Toll-like receptor 9-stimulated follicular B cells to plasma cell differentiation.
    Higuchi R; Tanaka K; Saito Y; Murakami D; Nakagawa T; Nutt SL; Ohkawa Y; Baba Y
    PNAS Nexus; 2024 Apr; 3(4):pgae152. PubMed ID: 38659975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals.
    Inui M; Hirota S; Hirano K; Fujii H; Sugahara-Tobinai A; Ishii T; Harigae H; Takai T
    Int Immunol; 2015 Jul; 27(7):345-55. PubMed ID: 25744616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TLR9 Signaling Suppresses the Canonical Plasma Cell Differentiation Program in Follicular B Cells.
    Baptista BJA; Granato A; Canto FB; Montalvão F; Tostes L; de Matos Guedes HL; Coutinho A; Bellio M; Vale AM; Nobrega A
    Front Immunol; 2018; 9():2281. PubMed ID: 30546358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients.
    Marasco E; Farroni C; Cascioli S; Marcellini V; Scarsella M; Giorda E; Piano Mortari E; Leonardi L; Scarselli A; Valentini D; Cancrini C; Duse M; Grimsholm O; Carsetti R
    Eur J Immunol; 2017 Jan; 47(1):131-143. PubMed ID: 27800605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
    Jahrsdörfer B; Hartmann G; Racila E; Jackson W; Mühlenhoff L; Meinhardt G; Endres S; Link BK; Krieg AM; Weiner GJ
    J Leukoc Biol; 2001 Jan; 69(1):81-8. PubMed ID: 11200072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage.
    Avery DT; Ellyard JI; Mackay F; Corcoran LM; Hodgkin PD; Tangye SG
    J Immunol; 2005 Apr; 174(7):4034-42. PubMed ID: 15778361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.